<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33462263</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation.</ArticleTitle><Pagination><StartPage>1740</StartPage><MedlinePgn>1740</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1740</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-81039-4</ELocationID><Abstract><AbstractText>Mesenchymal stromal/stem cells (MSCs) are characterized by neuroprotective, immunomodulatory, and neuroregenerative properties, which support their therapeutic potential for inflammatory/neurodegenerative diseases, including multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). One mode of action through which MSCs exert their immunomodulatory effects is release of extracellular vesicles that carry proteins, mRNAs, and microRNAs (miRNAs), which, once transferred, modify the function of target cells. We identified nine miRNAs significantly dysregulated in IFN-&#x3b3;-primed MSCs, but present at different levels in their derived&#xa0;small extracellular vesicles (s-EV). We show that miR-467f and miR-466q modulate the pro-inflammatory phenotype of activated N9 microglia cells and of primary microglia acutely isolated from late symptomatic SOD1<sup>G93A</sup> mice, a murine ALS model, by downregulating Tnf and Il1b expression. Further analysis of the mode of action of miR-467f and miR-466q indicated that they dampen the pro-inflammatory phenotype of microglia by modulating p38 MAPK signaling pathway via inhibition of expression of their target genes, Map3k8 and Mk2. Finally, we demonstrated that in vivo administration of s-EV leads to decreased expression of neuroinflammation markers in the spinal cord of EAE-affected mice, albeit without affecting disease course. Overall, our data suggest that MSC-derived exosomes could affect neuroinflammation possibly through specific immunomodulatory miRNAs acting on microglia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Giunti</LastName><ForeName>Debora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Marini</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Parodi</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usai</LastName><ForeName>Cesare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biophysics, National Research Council (CNR), Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Giambattista</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kerlero de Rosbo</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Uccelli</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy. dgiunti@neurologia.unige.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy. dgiunti@neurologia.unige.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="N">Encephalitis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="N">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045164" MajorTopicYN="N">Mesenchymal Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="N">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>19</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33462263</ArticleId><ArticleId IdType="pmc">PMC7814007</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-81039-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-81039-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Di Nicola M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838&#x2013;3843. doi: 10.1182/blood.V99.10.3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V99.10.3838</ArticleId><ArticleId IdType="pubmed">11986244</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008;8:726&#x2013;736. doi: 10.1038/nri2395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2395</ArticleId><ArticleId IdType="pubmed">19172693</ArticleId></ArticleIdList></Reference><Reference><Citation>Najar M, et al. Modulated expression of adhesion molecules and galectin-1: Role during mesenchymal stromal cell immunoregulatory functions. Exp. Hematol. 2010;38:922&#x2013;932. doi: 10.1016/j.exphem.2010.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2010.05.007</ArticleId><ArticleId IdType="pubmed">20570633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioud M, Mobergslien A, Boudabous A, Fl&#xf8;isand Y. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scand. J. Immunol. 2010;71:267&#x2013;274. doi: 10.1111/j.1365-3083.2010.02378.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2010.02378.x</ArticleId><ArticleId IdType="pubmed">20384870</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: Mode of action and pathways. Ann. N. Y. Acad. Sci. 2015;1351:114&#x2013;126. doi: 10.1111/nyas.12815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12815</ArticleId><ArticleId IdType="pubmed">26152292</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh MY, et al. Mesenchymal stem cells modulate the functional properties of microglia via TGF-&#x3b2; secretion. Stem Cells Transl. Med. 2016;5:1538&#x2013;1549. doi: 10.5966/sctm.2015-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0217</ArticleId><ArticleId IdType="pmc">PMC5070497</ArticleId><ArticleId IdType="pubmed">27400795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J. Neuroinflamm. 2014;11:135. doi: 10.1186/1742-2094-11-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-135</ArticleId><ArticleId IdType="pmc">PMC4128538</ArticleId><ArticleId IdType="pubmed">25088370</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubrand VE, et al. Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1. Glia. 2014;62:1932&#x2013;1942. doi: 10.1002/glia.22714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22714</ArticleId><ArticleId IdType="pubmed">24995657</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunti D, et al. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells. 2012;30:2044&#x2013;2053. doi: 10.1002/stem.1174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1174</ArticleId><ArticleId IdType="pubmed">22821677</ArticleId></ArticleIdList></Reference><Reference><Citation>Laroni A, de Rosbo NK, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection. Immunol. Lett. 2015;168:183&#x2013;190. doi: 10.1016/j.imlet.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2015.08.007</ArticleId><ArticleId IdType="pubmed">26296458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappia E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005;106:1755&#x2013;1761. doi: 10.1182/blood-2005-04-1496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-04-1496</ArticleId><ArticleId IdType="pubmed">15905186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovato L, Rosbo N, Uccelli A. Mesenchymal stem cells for the treatment of multiple sclerosis. Multiple Sclerosis Immunol. 2013 doi: 10.1007/978-1-4614-7953-6_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-7953-6_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, et al. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol. Med. 2012;18:794&#x2013;804. doi: 10.2119/molmed.2011.00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00498</ArticleId><ArticleId IdType="pmc">PMC3409288</ArticleId><ArticleId IdType="pubmed">22481270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Mariotti R. ALS pathogenesis and therapeutic approaches: The role of mesenchymal stem cells and extracellular vesicles. Front. Cell Neurosci. 2017;11:80. doi: 10.3389/fncel.2017.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00080</ArticleId><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CM, Suzuki M. Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis. Stem Cell Res. Ther. 2014;5:32. doi: 10.1186/scrt421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt421</ArticleId><ArticleId IdType="pmc">PMC4035799</ArticleId><ArticleId IdType="pubmed">25157751</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercelli A, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008;31:395&#x2013;405. doi: 10.1016/j.nbd.2008.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.05.016</ArticleId><ArticleId IdType="pubmed">18586098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, et al. Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Cell Tissue Res. 2014;357:571&#x2013;582. doi: 10.1007/s00441-014-1903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-1903-z</ArticleId><ArticleId IdType="pubmed">24906288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdoni E, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 2007;61:219&#x2013;227. doi: 10.1002/ana.21076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21076</ArticleId><ArticleId IdType="pubmed">17387730</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Jumah MA, Abumaree MH. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): A model of multiple sclerosis (MS) Int. J. Mol. Sci. 2012;13:9298&#x2013;9331. doi: 10.3390/ijms13079298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms13079298</ArticleId><ArticleId IdType="pmc">PMC3430298</ArticleId><ArticleId IdType="pubmed">22942767</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 2010;22:768&#x2013;774. doi: 10.1016/j.coi.2010.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2010.10.012</ArticleId><ArticleId IdType="pubmed">21093239</ArticleId></ArticleIdList></Reference><Reference><Citation>Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell. Biol. 2013;200:373&#x2013;383. doi: 10.1083/jcb.201211138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201211138</ArticleId><ArticleId IdType="pmc">PMC3575529</ArticleId><ArticleId IdType="pubmed">23420871</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaimes Y, Naaldijk Y, Wenk K, Leovsky C, Emmrich F. Mesenchymal stem cell-derived microvesicles modulate lipopolysaccharides-induced inflammatory responses to microglia cells. Stem Cells. 2017;35:812&#x2013;823. doi: 10.1002/stem.2541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2541</ArticleId><ArticleId IdType="pubmed">27862694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai RC, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214&#x2013;222. doi: 10.1016/j.scr.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2009.12.003</ArticleId><ArticleId IdType="pubmed">20138817</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30:1556&#x2013;1564. doi: 10.1002/stem.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1129</ArticleId><ArticleId IdType="pmc">PMC3495063</ArticleId><ArticleId IdType="pubmed">22605481</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarroya-Beltri C, Baixauli F, Guti&#xe9;rrez-V&#xe1;zquez C, S&#xe1;nchez-Madrid F, Mittelbrunn M. Sorting it out: Regulation of exosome loading. Semin. Cancer Biol. 2014;28:3&#x2013;13. doi: 10.1016/j.semcancer.2014.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2014.04.009</ArticleId><ArticleId IdType="pmc">PMC4640178</ArticleId><ArticleId IdType="pubmed">24769058</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci. 2016 doi: 10.3390/ijms17101712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17101712</ArticleId><ArticleId IdType="pmc">PMC5085744</ArticleId><ArticleId IdType="pubmed">27754357</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell CR, et al. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019 doi: 10.3390/cells8050467.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050467</ArticleId><ArticleId IdType="pmc">PMC6562906</ArticleId><ArticleId IdType="pubmed">31100966</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, et al. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int. Immunopharmacol. 2019;67:268&#x2013;280. doi: 10.1016/j.intimp.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.12.001</ArticleId><ArticleId IdType="pubmed">30572251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren G, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2:141&#x2013;150. doi: 10.1016/j.stem.2007.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2007.11.014</ArticleId><ArticleId IdType="pubmed">18371435</ArticleId></ArticleIdList></Reference><Reference><Citation>Krampera M. Mesenchymal stromal cell &#x2018;licensing&#x2019;: A multistep process. Leukemia. 2011;25:1408&#x2013;1414. doi: 10.1038/leu.2011.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2011.108</ArticleId><ArticleId IdType="pubmed">21617697</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigo T, et al. IFN-&#x3b3; orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways. J. Allergy Clin. Immunol. 2017;139:1667&#x2013;1676. doi: 10.1016/j.jaci.2016.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.09.004</ArticleId><ArticleId IdType="pubmed">27670240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: Database of exosomal proteins RNA and lipids. Nucleic Acids Res. 2012;40:D1241&#x2013;1244. doi: 10.1093/nar/gkr828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr828</ArticleId><ArticleId IdType="pmc">PMC3245025</ArticleId><ArticleId IdType="pubmed">21989406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona AE, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006;9:917&#x2013;924. doi: 10.1038/nn1715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1715</ArticleId><ArticleId IdType="pubmed">16732273</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry JD, Olschowka JA, O'Banion MK. Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. J. Neuroinflamm. 2014;11:98. doi: 10.1186/1742-2094-11-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-98</ArticleId><ArticleId IdType="pmc">PMC4060849</ArticleId><ArticleId IdType="pubmed">24889886</ArticleId></ArticleIdList></Reference><Reference><Citation>Saijo K, et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009;137:47&#x2013;59. doi: 10.1016/j.cell.2009.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.038</ArticleId><ArticleId IdType="pmc">PMC2754279</ArticleId><ArticleId IdType="pubmed">19345186</ArticleId></ArticleIdList></Reference><Reference><Citation>Squadrito ML, et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 2014;8:1432&#x2013;1446. doi: 10.1016/j.celrep.2014.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.07.035</ArticleId><ArticleId IdType="pubmed">25159140</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweep H, Gretz N. miRWalk2.0: A comprehensive atlas of microRNA-target interactions. Nat. Methods. 2015;12:697. doi: 10.1038/nmeth.3485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3485</ArticleId><ArticleId IdType="pubmed">26226356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachstetter AD, et al. Microglial p38&#x3b1; MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (A&#x3b2;) J. Neuroinflamm. 2011;8:79. doi: 10.1186/1742-2094-8-79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-79</ArticleId><ArticleId IdType="pmc">PMC3142505</ArticleId><ArticleId IdType="pubmed">21733175</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019 doi: 10.3390/cells8121605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121605</ArticleId><ArticleId IdType="pmc">PMC6952783</ArticleId><ArticleId IdType="pubmed">31835680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M, et al. Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer's disease. Neurochem. Res. 2018;43:2165&#x2013;2177. doi: 10.1007/s11064-018-2641-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2641-5</ArticleId><ArticleId IdType="pubmed">30259257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui GH, et al. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice. FASEB J. 2018;32:654&#x2013;668. doi: 10.1096/fj.201700600R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700600R</ArticleId><ArticleId IdType="pubmed">28970251</ArticleId></ArticleIdList></Reference><Reference><Citation>Laso-Garc&#xed;a F, et al. Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis. PLoS ONE. 2018;13:e0202590. doi: 10.1371/journal.pone.0202590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0202590</ArticleId><ArticleId IdType="pmc">PMC6145506</ArticleId><ArticleId IdType="pubmed">30231069</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadi H, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 2007;9:654&#x2013;659. doi: 10.1038/ncb1596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1596</ArticleId><ArticleId IdType="pubmed">17486113</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35:851&#x2013;858. doi: 10.1002/stem.2575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2575</ArticleId><ArticleId IdType="pubmed">28294454</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J. Neuroinflamm. 2020;17:47. doi: 10.1186/s12974-020-1726-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-1726-7</ArticleId><ArticleId IdType="pmc">PMC7001326</ArticleId><ArticleId IdType="pubmed">32019561</ArticleId></ArticleIdList></Reference><Reference><Citation>Noltet Hoen EN, et al. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 2012;40:9272&#x2013;9285. doi: 10.1093/nar/gks658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks658</ArticleId><ArticleId IdType="pmc">PMC3467056</ArticleId><ArticleId IdType="pubmed">22821563</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins PD, Dorronsoro A, Booker CN. Regulation of chronic inflammatory and immune processes by extracellular vesicles. J. Clin. Invest. 2016;126:1173&#x2013;1180. doi: 10.1172/JCI81131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81131</ArticleId><ArticleId IdType="pmc">PMC4811148</ArticleId><ArticleId IdType="pubmed">27035808</ArticleId></ArticleIdList></Reference><Reference><Citation>Krampera M, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386&#x2013;398. doi: 10.1634/stemcells.2005-0008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.2005-0008</ArticleId><ArticleId IdType="pubmed">16123384</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldh M, et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS ONE. 2010;5:e15353. doi: 10.1371/journal.pone.0015353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015353</ArticleId><ArticleId IdType="pmc">PMC3003701</ArticleId><ArticleId IdType="pubmed">21179422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Pulliam L. Exosomes as mediators of neuroinflammation. J. Neuroinflamm. 2014;11:68. doi: 10.1186/1742-2094-11-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-68</ArticleId><ArticleId IdType="pmc">PMC3994210</ArticleId><ArticleId IdType="pubmed">24694258</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M, et al. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat. Commun. 2015;6:7321. doi: 10.1038/ncomms8321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8321</ArticleId><ArticleId IdType="pmc">PMC4557301</ArticleId><ArticleId IdType="pubmed">26084661</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav SP, Kamath SP, Choolani M, Lu J, Dheen ST. microRNA-200b modulates microglia-mediated neuroinflammation via the cJun/MAPK pathway. J. Neurochem. 2014;130:388&#x2013;401. doi: 10.1111/jnc.12731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12731</ArticleId><ArticleId IdType="pubmed">24749688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu A, et al. MiR-124 contributes to M2 polarization of microglia and confers brain inflammatory protection via the C/EBP-&#x3b1; pathway in intracerebral hemorrhage. Immunol. Lett. 2017;182:1&#x2013;11. doi: 10.1016/j.imlet.2016.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.12.003</ArticleId><ArticleId IdType="pubmed">28025043</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel M, et al. IL-10 controls early microglial phenotypes and disease onset in ALS caused by misfolded superoxide dismutase 1. J. Neurosci. 2016;36:1031&#x2013;1048. doi: 10.1523/JNEUROSCI.0854-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0854-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZG, Buller B, Chopp M. Exosomes&#x2014;beyond stem cells for restorative therapy in stroke and neurological injury. Nat. Rev. Neurol. 2019;15:193&#x2013;203. doi: 10.1038/s41582-018-0126-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0126-4</ArticleId><ArticleId IdType="pubmed">30700824</ArticleId></ArticleIdList></Reference><Reference><Citation>Drommelschmidt K, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav. Immun. 2017;60:220&#x2013;232. doi: 10.1016/j.bbi.2016.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.11.011</ArticleId><ArticleId IdType="pubmed">27847282</ArticleId></ArticleIdList></Reference><Reference><Citation>Riazifar M, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019;13:6670&#x2013;6688. doi: 10.1021/acsnano.9b01004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.9b01004</ArticleId><ArticleId IdType="pmc">PMC6880946</ArticleId><ArticleId IdType="pubmed">31117376</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, et al. Inter- and intracellular signaling in amyotrophic lateral sclerosis: Role of p38 mitogen-activated protein kinase. Neurodegen. Dis. 2005;2:128&#x2013;134. doi: 10.1159/000089617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089617</ArticleId><ArticleId IdType="pubmed">16909017</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T, et al. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1. Neuropharmacology. 2017;123:433&#x2013;445. doi: 10.1016/j.neuropharm.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.020</ArticleId><ArticleId IdType="pubmed">28645622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part II, results and discussion. Brain Behav. 2013;3:431&#x2013;457. doi: 10.1002/brb3.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazma A, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001;29:365&#x2013;371. doi: 10.1038/ng1201-365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1201-365</ArticleId><ArticleId IdType="pubmed">11726920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gelfond JA, McManus LM, Shireman PK. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genom. 2009;10:407. doi: 10.1186/1471-2164-10-407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-10-407</ArticleId><ArticleId IdType="pmc">PMC2753550</ArticleId><ArticleId IdType="pubmed">19715577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco F, et al. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 2005;174:7268&#x2013;7277. doi: 10.4049/jimmunol.174.11.7268.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.11.7268</ArticleId><ArticleId IdType="pubmed">15905573</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006 doi: 10.1002/0471143030.cb0322s30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471143030.cb0322s30</ArticleId><ArticleId IdType="pubmed">18228490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona AE, Huang D, Sasse ME, Ransohoff RM. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 2006;1:1947&#x2013;1951. doi: 10.1038/nprot.2006.327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.327</ArticleId><ArticleId IdType="pubmed">17487181</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 2018;18:225&#x2013;242. doi: 10.1038/nri.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.125</ArticleId><ArticleId IdType="pubmed">29151590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353&#x2013;d361. doi: 10.1093/nar/gkw1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId><ArticleId IdType="pmc">PMC5210567</ArticleId><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimand J, et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA Cytoscape and EnrichmentMap. Nat. Protoc. 2019;14:482&#x2013;517. doi: 10.1038/s41596-018-0103-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-018-0103-9</ArticleId><ArticleId IdType="pmc">PMC6607905</ArticleId><ArticleId IdType="pubmed">30664679</ArticleId></ArticleIdList></Reference><Reference><Citation>Manders E, Verbbek F, Aten J. Measurement of colocalization of objects in dual-colour confocal images. J. Microsc. 1993;169:2. doi: 10.1111/j.1365-2818.1993.tb03313.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1993.tb03313.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Costes SV, et al. Automatic and quantitative measurement of protein&#x2013;protein colocalization in live cells. Biophys. J. 2004;86:3993&#x2013;4003. doi: 10.1529/biophysj.103.038422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.103.038422</ArticleId><ArticleId IdType="pmc">PMC1304300</ArticleId><ArticleId IdType="pubmed">15189895</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995;25:1951&#x2013;1959. doi: 10.1002/eji.1830250723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830250723</ArticleId><ArticleId IdType="pubmed">7621871</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. Exosomes mediate the cell-to-cell transmission of IFN-&#x3b1;-induced antiviral activity. Nat. Immunol. 2013;14:793&#x2013;803. doi: 10.1038/ni.2647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2647</ArticleId><ArticleId IdType="pubmed">23832071</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>